Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Cash & Current Investments (2016 - 2025)

Ptc Therapeutics has reported Cash & Current Investments over the past 14 years, most recently at $1.9 billion for Q4 2025.

  • Quarterly results put Cash & Current Investments at $1.9 billion for Q4 2025, up 70.69% from a year ago — trailing twelve months through Dec 2025 was $1.9 billion (up 70.69% YoY), and the annual figure for FY2025 was $1.9 billion, up 70.69%.
  • Cash & Current Investments for Q4 2025 was $1.9 billion at Ptc Therapeutics, up from $1.7 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for PTCT hit a ceiling of $2.0 billion in Q1 2025 and a floor of $286.3 million in Q1 2023.
  • Median Cash & Current Investments over the past 5 years was $880.8 million (2023), compared with a mean of $947.3 million.
  • Biggest five-year swings in Cash & Current Investments: tumbled 66.77% in 2022 and later skyrocketed 243.73% in 2024.
  • Ptc Therapeutics' Cash & Current Investments stood at $773.4 million in 2021, then plummeted by 46.89% to $410.7 million in 2022, then soared by 113.47% to $876.7 million in 2023, then increased by 29.99% to $1.1 billion in 2024, then surged by 70.69% to $1.9 billion in 2025.
  • The last three reported values for Cash & Current Investments were $1.9 billion (Q4 2025), $1.7 billion (Q3 2025), and $2.0 billion (Q2 2025) per Business Quant data.